From SBA-financed owner-operator buyouts to PE equity recaps, understand the deal structures driving medical weight loss clinic transactions in the lower middle market.
Medical weight loss clinic acquisitions in the $1M–$5M revenue range typically involve one of three core deal structures: SBA 7(a) financing for owner-operator transitions, asset purchases with patient-retention-based earnouts, or partial equity recapitalizations with PE-backed healthcare rollup platforms. The right structure depends on the seller's goals — full exit vs. partial liquidity — the clinic's revenue model, payer mix, and how dependent operations are on the owner-physician. Because GLP-1 program revenue can be volatile and patient churn is a real risk, buyers consistently seek downside protection through earnouts or seller notes tied to measurable retention milestones. Sellers who understand these levers before entering negotiations are far better positioned to protect valuation and close efficiently.
Find Weight Loss Clinic Businesses For SaleSBA 7(a) Loan with Seller Note
The most common structure for individual buyers or physician entrepreneurs acquiring a single weight loss clinic from a retiring owner. The SBA 7(a) loan covers 80–90% of the purchase price, with the seller carrying a subordinated note for the remaining 10–20%. The seller note is typically on standby for 24 months per SBA requirements, meaning no payments to the seller during that period.
Pros
Cons
Best for: Owner-retiring physician selling a single-location cash-pay or hybrid-model weight loss clinic to an individual buyer or small operator group with healthcare backgrounds
Asset Purchase with Patient Retention Earnout
Structured as an asset purchase — acquiring patient records, clinical protocols, equipment, lease rights, and staff contracts — with a portion of the purchase price contingent on post-close patient retention and revenue milestones measured at 12 and 24 months. Common when the seller is a key clinical provider or when the clinic's GLP-1 program revenue is newer and less proven over time.
Pros
Cons
Best for: Acquisitions where the selling physician is the primary provider, where the clinic is less than 3 years old, or where GLP-1 program revenue has grown rapidly and buyers need time to validate sustainability
Partial Equity Recapitalization with PE-Backed Platform
A PE-backed healthcare rollup platform acquires a majority stake — typically 60–80% — while the selling physician or operator retains 20–40% equity in the combined entity. The seller receives a significant cash distribution at close and participates in upside when the platform ultimately exits or recapitalizes, often at a higher multiple. Common when a clinic is multi-location or has $500K+ EBITDA.
Pros
Cons
Best for: Multi-location or high-EBITDA weight loss clinic operators seeking partial liquidity now while participating in the ongoing consolidation of the medical weight loss sector
Retiring NP-owned single-location cash-pay weight loss clinic with $400K EBITDA and strong membership model
$1,800,000
$1,440,000 SBA 7(a) loan (80%) + $360,000 seller note at 6% interest over 5 years (24-month standby per SBA requirements)
Buyer puts in $180,000 equity injection (10% of purchase price). Seller note begins amortizing in month 25. No earnout given clean 3-year financials and multi-provider team reducing key-person risk. Asset purchase structure. Seller stays on as paid consultant for 90-day transition period.
Physician-owned single-location GLP-1 clinic, 2 years operating, rapid revenue growth but limited retention history
$2,200,000
$1,760,000 at close (80%) funded through SBA 7(a) loan + $440,000 earnout paid in two tranches: $220,000 at month 12 if active patient count exceeds 400 and revenue is at or above $1.1M annualized, and $220,000 at month 24 if cumulative 24-month revenue exceeds $2.4M
Asset purchase. Seller remains as contracted medical director for 24 months at $120,000 annually. Earnout metrics defined as active patients completing at least one billable visit in the prior 60 days. Disputes resolved by independent healthcare CPA.
Multi-location medical weight loss operator with three clinics, $800K EBITDA, seeking partial liquidity and rollup participation
$4,500,000 enterprise value at close (on 5.6x EBITDA)
Seller receives $3,150,000 cash at close for 70% equity stake sold to PE-backed healthcare platform. Seller retains 30% equity in the combined platform entity. No earnout — clean financials, multi-provider staff, and proprietary employer wellness contracts support clean close.
Seller continues as Regional Medical Director at $180,000 annual compensation. Retained 30% equity subject to tag-along rights on future platform exit. PE platform targets 5-year hold with exit at 7–9x EBITDA, implying potential second distribution of $1.8M–$2.4M+ on retained equity based on platform growth.
Find Weight Loss Clinic Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
The most common structure in the lower middle market is an SBA 7(a) loan covering 80–90% of the purchase price combined with a seller note for the remaining 10–20%. This structure works well for individual buyers or physician entrepreneurs acquiring a single-location clinic from a retiring owner. When patient retention risk is higher — for example, when the selling physician is the primary provider — buyers often add an earnout component tied to 12- and 24-month revenue or active patient milestones.
Earnouts defer a portion of the purchase price — typically 15–25% — and pay it to the seller only if the business hits agreed-upon performance targets after close. In weight loss clinic deals, earnout triggers are usually tied to active patient count, total program revenue, or membership retention rates at 12 and 24 months post-close. The key is defining metrics precisely in the purchase agreement: what counts as an active patient, how revenue is measured, and who adjudicates disputes. Sellers who remain engaged as medical directors post-close are better positioned to hit earnout targets.
Yes, weight loss clinics are generally SBA-eligible businesses. SBA 7(a) loans are the most common financing tool for lower middle market clinic acquisitions in the $1M–$5M revenue range. Lenders will underwrite against 2–3 years of clean financial statements, recurring membership or program revenue, and the clinic's EBITDA. Clinics with commingled personal and business expenses, significant cash-pay revenue without adequate documentation, or regulatory compliance issues may face challenges qualifying. Working with an SBA lender experienced in healthcare or medical practice transactions significantly improves the process.
Medical weight loss clinics in the lower middle market currently trade at 3.5x–6x EBITDA depending on several factors. Clinics with strong patient retention, multi-provider teams, recurring membership revenue, and clean compliance histories command the higher end of the range. Owner-dependent practices with high churn, newer operating histories, or regulatory concerns trade closer to 3.5x–4x. The rapid rise of GLP-1 programs has created valuation uncertainty — buyers are carefully evaluating whether revenue growth is durable or tied to a drug availability window.
Patient records are among the most valuable — and most regulated — assets in a weight loss clinic acquisition. In an asset purchase, patient records transfer to the buyer, but this requires compliance with HIPAA's business associate agreement requirements and often patient notification under state law. Buyers must conduct a thorough HIPAA compliance review during due diligence, including patient consent documentation, data storage practices, and any prior breach history. Sellers should complete an internal HIPAA audit before going to market to avoid deal-killers surfacing late in the process.
In a traditional sale, the owner sells 100% of the business and exits. In a PE recapitalization, the owner sells a majority stake — typically 60–80% — receives a large cash distribution at close, and retains a minority equity position in the combined platform. This structure gives sellers immediate liquidity while allowing them to participate in future value creation as the PE platform grows through additional acquisitions. The tradeoff is loss of majority control and the illiquidity of retained equity until the platform's eventual exit, which may be 4–7 years away. For weight loss clinic operators with multiple locations or strong EBITDA, recaps are increasingly common as PE rollup activity in the sector intensifies.
More Weight Loss Clinic Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers